Bioburden Testing Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Report ID: GMI3869

Summary Methodology

Bioburden Testing Market size is projected to experience significant growth from 2019 to 2025.

The number of microorganisms living on any surface which has not been sterilized is called as bioburden. Bioburden testing is also called as microbial limit testing. This test is performed for quality control purposes on medical products and pharmaceutical products. In the field of pharmacy or medicine, the products or components used are needed to have microbial levels under control during handling and processing. The microbial limit testing or bioburden testing done on these products is done to find out that whether the requirements have been met or not. Bioburden testing is also done for assembly processes in manufacturing and routine monitoring of products and raw materials. The prime objective for conducting bioburden tests is to ensure safety.

The increasing number of medical devices will drive the bioburden testing market over the forecast period. Also, rising standards for quality control as per regulatory bodies and growing awareness amongst customer base of medical devices are driving the global bioburden testing market.

With advancements in pharmaceutical and medical field, the demand for bioburden tests will rise. Flourishing biotechnology industry will augment the growth of bioburden testing market over the forthcoming years. Safety concerns for consumables such as food and beverages increasing, and market players involved in this business are making sure the requirements are met. Such factors will boost the bioburden testing market in the forthcoming years.

Moreover, technological developments related to improvements in the bioburden testing are major factors that will drive market growth. However, stringent government regulations, product recalls, high costs related to the bioburden testing equipment could restrict industry growth especially in emerging economies.

The contract manufacturing organization segment is expected to show the highest CAGR by end-use in the global bioburden testing market throughout the forecast period due to high rate of manufacturing outsourcing in biotechnology and pharmaceutical companies. The key factor contributing to the growth of raw material testing market is the improving quality standards for finished products throughout the globe.

The U.S. held the largest share in the global bioburden testing market in 2018 due to the availability of highly developed healthcare infrastructure, huge investment in pharmaceutical R&D, advanced technology as well as the presence of major market players in the region. Furthermore, the high healthcare expenditure will fuel market growth.

Japan is expected to show significant growth in the bioburden testing market over the forecast period due to advancements in technology, rising quality standards in biotechnology and pharmacy and growing developments in the healthcare infrastructure. The above-mentioned factors will boost the demand for Bioburden Testing.

Some of the key industry players include Charles River, Merck KGaA, SGS SA, WuXi AppTec, Becton, Dickinson and Company, NAMSA, Nelson Laboratories, LLC, Thermo Fisher Scientific, biomérieux SA, and Pacific BioLabs. Major strategic initiatives adopted by industry players include partnerships, mergers and innovative product launches to expand their business product portfolio.

Bioburden Testing Market by Product, 2014-2025 (USD Million)

  • Consumables
  • Instrument
    • PCR
    • Microscope

Bioburden Testing Market by Test, 2014-2025 (USD Million)

  • Anerobic
  • Mold
  • Aerobic
  • Spore

Bioburden Testing Market by Application, 2014-2025 (USD Million)

  • Raw Material
  • Medical Device
  • Sterility Testing

Bioburden Testing Market by End-use, 2014-2025 (USD Million)

  • Pharmaceutical
  • Biotechnology
  • Contract Manufacturing Organization

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Singapore
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • Saudi Arabia
    • South Africa

Company Profiles:

  • Charles River
  • Merck KGaA
  • SGS SA
  • WuXi AppTec
  • Becton, Dickinson and Company
  • Nelson Laboratories LLC
  • Thermo Fisher Scientific
  • Biomérieux SA
  • Pacific BioLabs

What Information does this report contain?

Historical data coverage: 2016 to 2020; Growth Projections: 2021 to 2027.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Customize this Report

Pre Book Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X